Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The IRST Somatic Cell Therapy Laboratory is a specialized Good Manufacturing Practice (GMP) facility located within the IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori in Meldola, Italy. The laboratory is dedicated to the development and production of Advanced Therapy Medicinal Products (ATMPs) for cancer immunotherapy, specifically focusing on somatic cell therapies. Authorized by the Italian Medicines Agency (AIFA), it produces autologous dendritic cell vaccines and tumor-infiltrating lymphocytes (TILs) for clinical trials. The facility serves as a critical translational bridge, moving innovative cell-based treatments from the research bench to oncology patients. It operates as a non-profit entity within the Italian national healthcare system, supporting both internal and collaborative clinical research programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IRST Somatic Cell Therapy Laboratory.